LEADER 01159nam--2200397---450-
001 990005847800203316
005 20130523134953.0
010   $a978-88-6689-283-0
035   $a000584780
035   $aUSA01000584780
035   $a(ALEPH)000584780USA01
035   $a000584780
100   $a20130523d2013----km-y0itay50------ba
101   $aita
102   $aIT
105   $a||||||||001yy
200 1 $aCodice del condominio$espiegato con esempi pratici, dottrina e giurisprudenza$fa cura di Luigi Tramontano
205   $a2. ed
210   $aPiacenza$cLa Tribuna$d2013
215   $a1309 p.$d22 cm
225 2 $aTribuna Studium
410  0$1001$12001$aTribuna Studium
454  1$12001
461  1$1001-------$12001
676   $a346.45033
702  1$aTRAMONTANO,$bLuigi
801  0$aIT$bsalbc$gISBD
912   $a990005847800203316
951   $aXXV.1.A. 448$b77068 G.$cXXV.1.A.$d00341087
959   $aBK
969   $aGIU
979   $aFIORELLA$b90$c20130523$lUSA01$h1347
979   $aFIORELLA$b90$c20130523$lUSA01$h1349
979   $aCHIARA$b90$c20150108$lUSA01$h1543
996   $aCodice del condominio$91086878
997   $aUNISA

LEADER 02665nam  2200565Ia 450 
001 9910780434103321
005 20230721023434.0
010   $a1-282-41254-X
010   $a9786612412547
010   $a0-309-13837-X
035   $a(CKB)2420000000001444
035   $a(EBL)3378540
035   $a(SSID)ssj0000438155
035   $a(PQKBManifestationID)12160749
035   $a(PQKBTitleCode)TC0000438155
035   $a(PQKBWorkID)10452362
035   $a(PQKB)11642112
035   $a(MiAaPQ)EBC3378540
035   $a(Au-PeEL)EBL3378540
035   $a(CaPaEBR)ebr10347043
035   $a(CaONFJC)MIL241254
035   $a(OCoLC)923280906
035   $a(EXLCZ)992420000000001444
100   $a20090921d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aInitial national priorities for comparative effectiveness research$b[electronic resource] /$fCommittee on Comparative Effectiveness Research Prioritization, Board on Health Care Services, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2009
215   $a1 online resource (252 p.)
300   $aDescription based upon print version of record.
311   $a0-309-13836-1 
320   $aIncludes bibliographical references.
327   $a""Reviewers""; ""Foreword""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 What Is Comparative Effectiveness Research?""; ""3 Obtaining Input to Identify National Priorities for Comparative Effectiveness Research""; ""4 The Criteria and Process for Setting Priorities""; ""5 Priorities for Study""; ""6 Essential Priorities for a Robust CER Enterprise""; ""Appendix A: Public Meeting Agendaa???March 20, 2009""; ""Appendix B: Stakeholder Questionnaire""; ""Appendix C: Data Tables: Burden of Disease and Variation of Care""
327   $a""Appendix D: Cardiovascular and Peripheral Vascular Cover Sheet""""Appendix E: Definitions of Medical Terminology in CER Priority List""; ""Appendix F: Committee Biographies""
606   $aMedicine$xResearch$zUnited States
606   $aMedical policy$zUnited States
615  0$aMedicine$xResearch
615  0$aMedical policy
676   $a610.72073
712 02$aInstitute of Medicine (U.S.).$bCommittee on Comparative Effectiveness Research Prioritization.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910780434103321
996   $aInitial national priorities for comparative effectiveness research$93800835
997   $aUNINA